Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases.

Abstract:

:To investigate local control and radiation-induced brain necrosis in patients with melanoma brain metastases who received complete resection plus fractionated stereotactic radiosurgery (fSRS, 3 × 9 Gy) or fSRS alone. Factors associated with the clinical outcomes and the development of brain necrosis have been assessed. One hundred and twenty consecutive patients with 137 melanoma brain metastases who received surgery plus fSRS (S + fSRS) or fSRS alone were analyzed. All lesions evaluated in the study were treated with a dose of 27 Gy given in 3 fractions over three consecutive days. Cumulative incidence analysis was used to compare local failure (LF), distant brain failure (DBF), and radiation-induced brain necrosis (RN) between groups from the time of SRS. At a median follow-up of 13 months, median OS times and 1-year survival rates were comparable: S + fSRS, 14 months and 85%; fSRS, 12 months and 85% (p = 0.2). Median DBF did not differ significantly by group, being 14 months for both groups. Nine patients who received S + fSRS and 20 patients treated with fSRS recurred locally (p = 0.03). Six-month and 1-year LF rates were 5 and 12% in S + fSRS group and 17 and 28% in fSRS group (p = 0.02). RN occurred in 21 patients (S + fSRS, n = 14; fSRS, n = 7; p = 0.1). The cumulative 1-year incidence of RN was 13% after S + fSRS and 8% after fSRS (p = 0.15). In conclusion, postoperative SRS (3 × 9 Gy) to the resection cavity is an effective treatment modality for melanoma brain metastases associated with better local control as compared with fSRS alone.

journal_name

J Neurooncol

authors

Minniti G,Paolini S,D'Andrea G,Lanzetta G,Cicone F,Confaloni V,Bozzao A,Esposito V,Osti M

doi

10.1007/s11060-017-2394-z

subject

Has Abstract

pub_date

2017-05-01 00:00:00

pages

455-462

issue

3

eissn

0167-594X

issn

1573-7373

pii

10.1007/s11060-017-2394-z

journal_volume

132

pub_type

杂志文章
  • Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy.

    abstract::Purpose of this study was to determine the effect of waiting time for radiotherapy on overall survival of patients with glioblastoma treated in the EORTC-NCIC trial at 18 centers in France. A total of 400 adult patients with glioblastoma who were treated between January 1, 2006 and December 31, 2006 were included. The...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-012-0883-7

    authors: Noel G,Huchet A,Feuvret L,Maire JP,Verrelle P,Le Rhun E,Aumont M,Thillays F,Sunyach MP,Henzen C,Missohou F,de Crevoisier R,Bondiau PY,Collin P,Durando X,Truc G,Kerr C,Bernier V,Clavier JB,Atlani D,D'Hombres A,Vi

    更新日期:2012-08-01 00:00:00

  • Blood flow and blood-to-tissue transport in 9L gliosarcomas: the role of the brain tumor model in drug delivery research.

    abstract::We used double-label quantitative autoradiography to measure blood flow (with 131I-iodoantipyrine) and blood-to-tissue transport of 14C-alpha aminoisobutyric acid, AIB) in thirteen 9L gliosarcomas transplanted intracerebrally into Fischer-344 rats. Microscopically, the typical pattern of 9L tumor growth was observed: ...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1007/BF00165526

    authors: Fross RD,Warnke PC,Groothuis DR

    更新日期:1991-12-01 00:00:00

  • Histopathological and cytogenetic findings in benign, atypical and anaplastic human meningiomas: a study of 60 tumors.

    abstract::Meningiomas may display benign (Grade I), atypical (Grade II) and anaplastic (Grade III) histopathological findings. The cytogenetic studies strongly suggest that secondary changes (moreover loss of chromosome 22) appear to be associated with more atypical features and with greater clinical aggressivity. We studied 60...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1023/a:1006454107467

    authors: Cerdá-Nicolás M,López-Gineś C,Pérez-Bacete M,Barcia-Salorio JL,Llombart-Bosch A

    更新日期:2000-04-01 00:00:00

  • Imatinib and docetaxel in combination can effectively inhibit glioma invasion in an in vitro 3D invasion assay.

    abstract::The main problem in the treatment of malignant astrocytomas is their invasive behaviour. Successful resection of the main tumour mass cannot prevent recurrence due to single cells invading the surrounding brain parenchyma at the time of diagnosis. The classical combination therapy, PCV (Procarbazine, CCNU and Vincrist...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-010-0246-1

    authors: Kinsella P,Clynes M,Amberger-Murphy V

    更新日期:2011-01-01 00:00:00

  • Neuroimaging classification of progression patterns in glioblastoma: a systematic review.

    abstract:BACKGROUND:Our primary objective was to report the current neuroimaging classification systems of spatial patterns of progression in glioblastoma. In addition, we aimed to report the terminology used to describe 'progression' and to assess the compliance with the Response Assessment in Neuro-Oncology (RANO) Criteria. ...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-018-2843-3

    authors: Piper RJ,Senthil KK,Yan JL,Price SJ

    更新日期:2018-08-01 00:00:00

  • Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery.

    abstract::Patients with metastatic disease are living longer and may be confronted with locally or regionally recurrent brain metastases (BM) after prior stereotactic radiosurgery (SRS) or fractionated stereotactic radiotherapy (FSRT). This study analyzes outcomes in patients without prior whole brain radiotherapy (WBRT) who we...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-013-1191-6

    authors: Kim DH,Schultheiss TE,Radany EH,Badie B,Pezner RD

    更新日期:2013-10-01 00:00:00

  • Inhibition of collagenolytic activity relates to quantitative reduction of invasion in vitro in a c-Ha-ras transfected glial cell line.

    abstract::The function of proteases in brain tumor invasion is currently not well established. For tumors of epithelial and fibromatous origin collagenase production can enhance the invasive capacity of cells to penetrate basement membranes. We showed previously that a c-Ha-ras transformed glial cell line (CxT24neo3) invaded ha...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/BF01052898

    authors: Boghaert ER,Chan SK,Zimmer C,Grobelny D,Galardy RE,Vanaman TC,Zimmer SG

    更新日期:1994-01-01 00:00:00

  • Treatment of recurrent esthesioneuroblastoma with combined intra-arterial chemotherapy. A case report.

    abstract::A 65 year old woman presented with a recurrent locally advanced esthesioneuroblastoma. She had earlier been treated with radiation followed by surgery. The recurrence was located in earlier radiated tissues with intracranial infiltration. She underwent treatment with combined intra-arterial chemotherapy (BCNU) i.a., v...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/BF00162764

    authors: Watne K,Hager B

    更新日期:1987-01-01 00:00:00

  • Paucity of retinoic acid receptor alpha (RAR alpha) nuclear immunostaining in gliomas and inability of retinoic acid to influence neural cell adhesion molecule (NCAM) expression.

    abstract::Neural cell adhesion molecule (NCAM) is down-regulated during periods of embryological cell migration and may be important in local tumor migration or metastases. Conflicting information exists in the literature about NCAM expression in human glial tumors and little is known about its expression in human brain metasta...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1023/a:1006162211296

    authors: Kleinschmidt-DeMasters BK,Orr EA,Savelieva E,Owens GC,Kruse CA

    更新日期:1999-01-01 00:00:00

  • Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?

    abstract::Systemic high-dose methotrexate (HD-MTX) is the most effective chemotherapeutic agent in the treatment of primary central nervous system lymphoma (PCNSL). Leptomeningeal involvement is common and intrathecal methotrexate (IT-MTX) is frequently used in combination with HD-MTX, but its benefits are not established. Usin...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1023/a:1016077907952

    authors: Khan RB,Shi W,Thaler HT,DeAngelis LM,Abrey LE

    更新日期:2002-06-01 00:00:00

  • The cell growth inhibitory transcription factor C/EBPdelta is expressed in human meningiomas in association with low histological grade and proliferation index.

    abstract::CCAAT/enhancer binding protein (C/EBP) delta is a transcription factor which has been demonstrated to mediate the growth arrest of mammary and prostate cancer cell lines. It is induced by several stimuli including inflammatory cytokines. In this study, C/EBPdelta immunohistochemical expression was assessed in 49 menin...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-009-0024-0

    authors: Barresi V,Vitarelli E,Cerasoli S,Barresi G

    更新日期:2010-04-01 00:00:00

  • An integrated approach to the treatment of chiasmatic-hypothalamic gliomas.

    abstract::The treatment of visual pathway gliomas is controversial. The many retrospective studies reporting outcome data for patients with chiasmatic/hypothalamic gliomas are difficult to interpret for several reasons. First the natural history of these tumors is erratic with some reports suggesting that most visual pathway gl...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1007/BF00250197

    authors: Garvey M,Packer RJ

    更新日期:1996-05-01 00:00:00

  • Signal transduction molecules in gliomas of all grades.

    abstract:PURPOSE:To interrogate grade II, III, and IV gliomas and characterize the critical effectors within the PI3-kinase pathway upstream and downstream of mTOR. Experimental design Tissues from 87 patients who were treated at UCSF between 1990 and 2004 were analyzed. Twenty-eight grade II, 17 grade III glioma, 26 grade IV g...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-008-9683-5

    authors: Ermoian RP,Kaprealian T,Lamborn KR,Yang X,Jelluma N,Arvold ND,Zeidman R,Berger MS,Stokoe D,Haas-Kogan DA

    更新日期:2009-01-01 00:00:00

  • Negative impact of leukoaraiosis on the incidence of brain metastases in patients with lung cancer.

    abstract::The embolization of cancer cells to cerebral vessels occurs early in the multi-step metastatic process. We aimed to determine whether the presence of leukoaraiosis (LA) before treatment would predict the development of brain metastases (BM) in patients with lung cancer. Between January 2014 and June 2015, 1007 patient...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-017-2574-x

    authors: Hayashi N,Mitsuya K,Nakasu Y,Naito T,Ohka F,Takahashi T

    更新日期:2017-11-01 00:00:00

  • A new technique to register proliferation of clonogenic cells from brain tumors.

    abstract::The soft agar technique for culturing human clonogenic tumor cells has been usefully applied for predicting individual clinical responses to chemotherapy, for screening of new antineoplastic drugs, and in basic biological research. The counting of colonies formed by clonogenic cells is, however, a rather time consumin...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/BF00165180

    authors: Unsgaard G,Larsen B,Dalen A,Vik R,Ringkjøb R

    更新日期:1985-01-01 00:00:00

  • JCOG0911 INTEGRA study: a randomized screening phase II trial of interferonβ plus temozolomide in comparison with temozolomide alone for newly diagnosed glioblastoma.

    abstract:PURPOSE:This study explored the superiority of temozolomide (TMZ) + interferonβ (IFNβ) to standard TMZ as treatment for newly diagnosed glioblastoma (GBM) via randomized phase II screening design. EXPERIMENTAL DESIGN:Eligibility criteria included histologically proven GBM, with 50% of the tumor located in supratentori...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1007/s11060-018-2831-7

    authors: Wakabayashi T,Natsume A,Mizusawa J,Katayama H,Fukuda H,Sumi M,Nishikawa R,Narita Y,Muragaki Y,Maruyama T,Ito T,Beppu T,Nakamura H,Kayama T,Sato S,Nagane M,Mishima K,Nakasu Y,Kurisu K,Yamasaki F,Sugiyama K,Onishi

    更新日期:2018-07-01 00:00:00

  • Advances in genetic and epigenetic analyses of gliomas: a neuropathological perspective.

    abstract::Gliomas, the most common malignant primary brain tumors, are universally fatal once they progress from low-grade into high-grade neoplasms. In recent years, we have accumulated unprecedented data about the genetic and epigenetic abnormalities in gliomas; yet, our appreciation of how these deadly tumors arise is still ...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1007/s11060-014-1499-x

    authors: Tsankova NM,Canoll P

    更新日期:2014-09-01 00:00:00

  • Frequency and clinical significance of chromosome 7 and 10 aneuploidies, amplification of the EGFR gene, deletion of PTEN and TP53 genes, and 1p/19q deficiency in a sample of adult patients diagnosed with glioblastoma from Southern Brazil.

    abstract::Glioblastoma stands out as the most frequent central nervous system neoplasia, presenting a poor prognosis. The aim of this study was to verify the frequency and clinical significance of the aneuploidy of chromosomes 7 and 10, EGFR amplification, PTEN and TP53 deletions and 1p/19q deficiency in adult patients diagnose...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-017-2606-6

    authors: Koshiyama DB,Trevisan P,Graziadio C,Rosa RFM,Cunegatto B,Scholl J,Provenzi VO,de Sá AP,Soares FP,Velho MC,de A P Filho N,Oliveira CA,Zen PRG

    更新日期:2017-12-01 00:00:00

  • A phase II study of nimustine hydrochloride, cisplatin, and etoposide combination chemotherapy for supratentorial malignant gliomas.

    abstract::Twenty-eight patients who were previously treated by aggressive surgery and radiation and were diagnosed with supratentorial malignant gliomas received a combination of nimustine hydrochloride; 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU), cisplatin and etoposide (ACE ...

    journal_title:Journal of neuro-oncology

    pub_type: 临床试验,杂志文章

    doi:10.1023/a:1006486528418

    authors: Beppu T,Yoshida Y,Arai H,Wada T,Suzuki M,Ogawa A,Hakozaki S,Kubo N

    更新日期:2000-09-01 00:00:00

  • Stereotactic radiosurgery training patterns across neurosurgical programs: a multi-national survey.

    abstract:INTRODUCTION:The field of neurosurgery has witnessed a dramatic increase in the use of stereotactic radiosurgery (SRS) as a modality to treat various cranial and spinal pathologies. However, studies have consistently demonstrated disparities in SRS training. Accordingly, the present study represents a cross-sectional a...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-020-03670-x

    authors: Samuel N,Trifiletti DM,Quinones-Hinojosa A,Lunsford LD,Sheehan J

    更新日期:2021-01-04 00:00:00

  • miR-331-3p regulates expression of neuropilin-2 in glioblastoma.

    abstract::Aberrant expression of microRNAs (miRNAs), a class of small non-coding regulatory RNAs, has been implicated in the development and progression of high-grade gliomas. However, the precise mechanistic role of many miRNAs in this disease remains unclear. Here, we investigate the functional role of miR-331-3p in glioblast...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-013-1271-7

    authors: Epis MR,Giles KM,Candy PA,Webster RJ,Leedman PJ

    更新日期:2014-01-01 00:00:00

  • Vertebral collapse with quadraparesis due to metastatic gliobla multiforme: case report and review of the literature.

    abstract::A case is reported of a patient rendered quadraparetic following collapse of a cervical vertebra due to neoplastic invasion by metastatic glioblastoma multiforme. The case is discussed in light of a review of the world literature regarding the clinical incidence and significance of metastasis of glial tumors. It is re...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1007/BF01324700

    authors: Chesnut RM,Abitbol JJ,Chamberlain M,Marshall LF

    更新日期:1993-05-01 00:00:00

  • Deletions of chromosomes 1p and 19q are detectable on frozen smears of gliomas by FISH: usefulness for stereotactic biopsies.

    abstract::Among diffuse gliomas, oligodendrogliomas may account for 25% of cases. They have a better prognosis and chemosensitivity as compared to astrocytomas. Genetic studies have shown a correlation between oligodendrocyte phenotype and presence of 1p/19q deletions. In addition, these deletions are of prognostic value. The a...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1023/b:neon.0000027758.10286.c1

    authors: Bouvier C,Roll P,Quilichini B,Metellus P,Calisti A,Gilles S,Chinot O,Fina F,Martin PM,Figarella-Branger D

    更新日期:2004-06-01 00:00:00

  • Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion.

    abstract::Membrane-type MMPs (MT-MMPs) constitute a growing subclass of recently identified matrix metalloproteinases (MMPs). In addition to the highly conserved MMP functional domains, the MT-MMPs have additional insertion sequences (IS) that confer unique functional roles. While most of the MMPs are secreted, the MT-MMPs are ...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1023/a:1012213604731

    authors: Fillmore HL,VanMeter TE,Broaddus WC

    更新日期:2001-06-01 00:00:00

  • Early imaging marker of progressing glioblastoma: a window of opportunity.

    abstract:PURPOSE:Therapeutic intervention at glioblastoma (GBM) progression, as defined by current assessment criteria, is arguably too late as second-line therapies fail to extend survival. Still, most GBM trials target recurrent disease. We propose integration of a novel imaging biomarker to more confidently and promptly defi...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/s11060-020-03565-x

    authors: Gatson NTN,Bross SP,Odia Y,Mongelluzzo GJ,Hu Y,Lockard L,Manikowski JJ,Mahadevan A,Kazmi SAJ,Lacroix M,Conger AR,Vadakara J,Nayak L,Chi TL,Mehta MP,Puduvalli VK

    更新日期:2020-07-01 00:00:00

  • A supratentorial primitive neuroectodermal tumor in an adult: a case report and review of the literature.

    abstract::Supratentorial primitive neuroectodermal tumors (sPNET) occurring in adults are rare. Only 56 such cases have been previously reported. This report documents a 56-year-old male who presented with the chief complaint of right facial palsy. Magnetic resonance imaging (MRI) revealed left frontal and bilateral periventric...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1007/s11060-007-9466-4

    authors: Ohba S,Yoshida K,Hirose Y,Ikeda E,Kawase T

    更新日期:2008-01-01 00:00:00

  • Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas.

    abstract::Meningioma is a common intracranial tumor, originating from the meninges of the skull or spinal canal. Most meningiomas are benign tumors, however atypical or anaplastic tumors can be found in 6% of cases. Patients with asymptomatic small benign meningiomas can be followed without therapy, but in symptomatic patients ...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1007/s11060-008-9734-y

    authors: Sioka C,Kyritsis AP

    更新日期:2009-03-01 00:00:00

  • Accelerator-based epithermal neutron sources for boron neutron capture therapy of brain tumors.

    abstract::This paper reviews the development of low-energy light ion accelerator-based neutron sources (ABNSs) for the treatment of brain tumors through an intact scalp and skull using boron neutron capture therapy (BNCT). A major advantage of an ABNS for BNCT over reactor-based neutron sources is the potential for siting withi...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章,评审

    doi:10.1007/BF02699931

    authors: Blue TE,Yanch JC

    更新日期:2003-03-01 00:00:00

  • Metabolic manipulation of glioblastoma in vivo by retrograde microdialysis of L-2, 4 diaminobutyric acid (DAB).

    abstract:OBJECTIVES:To study the metabolic effects in vivo of L-2, 4 diaminobutyric acid (DAB) administered by retrograde microdialysis in glioblastoma and to evaluate the feasibility of the technique. METHODS:In 10 patients with glioblastoma, a stereotactic biopsy was performed followed by implantation of microdialysis cathet...

    journal_title:Journal of neuro-oncology

    pub_type: 临床试验,杂志文章

    doi:10.1007/s11060-006-9186-1

    authors: Bergenheim AT,Roslin M,Ungerstedt U,Waldenström A,Henriksson R,Ronquist G

    更新日期:2006-12-01 00:00:00

  • Metastatic epidural osteosarcoma initially diagnosed as cisplatin neuropathy.

    abstract::Unexpected early epidural spinal metastasis in a case of osteosarcoma occurred in a patient receiving treatment with cis-diamminedichloroplatinum-II (cisplatin). The initial neurologic symptomatology manifested as paresthesias in the feet which developed 2 months after initiation of treatment (cumulative dose of cispl...

    journal_title:Journal of neuro-oncology

    pub_type: 杂志文章

    doi:10.1007/BF00165378

    authors: Shimizu H,Jaffe N,Kleinerman E

    更新日期:1986-01-01 00:00:00